Published in Adv Clin Chem on January 01, 2007
Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea. Am J Respir Crit Care Med (2009) 1.13
Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain. Inflamm Res (2010) 0.88
Electrospray ionization Fourier transform mass spectrometric analysis of intact bikunin glycosaminoglycan from normal human plasma. Int J Mass Spectrom (2011) 0.83
The effect of ulinastatin on hemostasis in major orthopedic surgery. Korean J Anesthesiol (2010) 0.83
A pathogenic nematode targets recognition proteins to avoid insect defenses. PLoS One (2013) 0.82
Ulinastatin reduces the resistance of liver cancer cells to epirubicin by inhibiting autophagy. PLoS One (2015) 0.81
The ultra-early protective effect of ulinastatin on rabbit acute lung injury induced by paraquat. BMC Emerg Med (2013) 0.80
Urine bikunin as a marker of renal impairment in Fabry's disease. Biomed Res Int (2013) 0.78
High level expression of bikunin in Pichia pastoris by fusion of human serum albumin. AMB Express (2012) 0.75
Effect of ulinastatin on the rocuronium-induced neuromuscular blockade. Korean J Anesthesiol (2012) 0.75
Estimation of warfarin maintenance dose based on VKORC1 (-1639 G>A) and CYP2C9 genotypes. Clin Chem (2007) 2.56
Violent behavior and hallucination in a 32-year-old patient. Clin Chem (2013) 2.02
Proteomics: a new diagnostic frontier. Clin Chem (2006) 1.82
Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA). J Clin Microbiol (2004) 1.55
Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations. Pharmacogenomics (2008) 1.50
De novo biosynthesis and radiolabeling of mammalian digitalis-like factors. Clin Chem (2004) 1.43
Warfarin dose adjustments based on CYP2C9 genetic polymorphisms. J Thromb Thrombolysis (2002) 1.27
Necrotizing peripheral vasculitis/vasculopathy following the use of cocaine laced with levamisole. J Burn Care Res (2012) 1.12
From personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice system. Pharmacogenomics (2010) 1.01
Improved sensitivity for methotrexate analysis using enzyme multiplied immunoassay technique on the Siemens Viva-E instrument. Ther Drug Monit (2012) 0.96
Mammalian cardenolides in cancer prevention and therapeutics. Ther Drug Monit (2008) 0.92
Strategies for developing biomarkers of heart failure. Clin Chem (2003) 0.91
The journey to regulation of protein-based multiplex quantitative assays. Clin Chem (2011) 0.90
Interactive modeling for ongoing utility of pharmacogenetic diagnostic testing: application for warfarin therapy. Clin Chem (2009) 0.90
Human adrenal cells in culture produce both ouabain-like and dihydroouabain-like factors. Clin Chem (2002) 0.85
Prospective pilot trial of PerMIT versus standard anticoagulation service management of patients initiating oral anticoagulation. Thromb Haemost (2012) 0.85
Dynamic pharmacogenetic models in anticoagulation therapy. Clin Lab Med (2008) 0.84
Circulating tumor cells: a review of present methods and the need to identify heterogeneous phenotypes. Ann Clin Lab Sci (2013) 0.83
Catastrophic gastrointestinal injury due to battery acid ingestion. J Emerg Med (2008) 0.82
Therapeutic monitoring of opioids: a sensitive LC-MS/MS method for quantitation of several opioids including hydrocodone and its metabolites. Ther Drug Monit (2013) 0.82
The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone. Pain Physician (2013) 0.82
Serum proteomic patterns associated with sleep-disordered breathing in children. Pediatr Res (2006) 0.82
Simultaneous determination of 7 N-acetyltransferase-2 single-nucleotide variations by allele-specific primer extension assay. Clin Chem (2006) 0.81
Unexpected suppression of immunoassay results by cross-reactivity: now a demonstrated cause for concern. Clin Chem (2002) 0.79
Dialysis of saliva improves accuracy of saliva lithium determinations. Bipolar Disord (2004) 0.79
Urinary proteins for the diagnosis of obstructive sleep apnea syndrome. Methods Mol Biol (2010) 0.79
Aberrant regulation of endogenous ouabain-like factor in bipolar subjects. Psychiatry Res (2010) 0.78
Digoxin-like immunoreactive factors induce apoptosis in human acute T-cell lymphoblastic leukemia. Clin Chem (2007) 0.78
The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy. Clin Lab Med (2008) 0.77
Pesticide-induced quadriplegia in a 55-year-old woman. Am J Forensic Med Pathol (2014) 0.76
Sensitive noninvasive marker for the diagnosis of probable bacterial or viral infection. J Clin Lab Anal (2004) 0.76
Immunological evaluation of urinary trypsin inhibitors in blood and urine: role of N- & O-linked glycoproteins. Glycoconj J (2007) 0.76
Suppression of cytochrome P450 2E1 promoter activity by interferon-gamma and loss of response due to the -71G>T nucleotide polymorphism of the CYP2E1*7B allele. J Pharmacol Exp Ther (2003) 0.76
Digoxin-like immunoreactive factor in human cerebrospinal fluid. J Neuropsychiatry Clin Neurosci (2007) 0.76
Genotyping three SNPs affecting warfarin drug response by isothermal real-time HDA assays. Clin Chim Acta (2010) 0.75
Guidelines and recommendations in laboratory medicine. Clin Chem (2002) 0.75
Fine-tuning pharmacogenetics: paradigm for linking laboratory results to clinical action. Clin Chem (2004) 0.75
Application of bioaffinity mass spectrometry for analysis of ligands. Ther Drug Monit (2005) 0.75
Pharmacogenetics as related to the practice of cardiothoracic and vascular anesthesia. J Cardiothorac Vasc Anesth (2004) 0.75
Identification of a synonymous polymorphism within the cytochrome P4502C9 gene that interferes with identification of the CYP2C9*2 allele. Ther Drug Monit (2007) 0.75
Cardioactive steroid poisoning from an herbal cleansing preparation. Ann Emerg Med (2003) 0.75
A diagnostic informatics approach for stratifying risk outcome based on combined genotype effects. Ther Drug Monit (2012) 0.75
Preface. Pharmacogenetics and its application to medicine by way of the clinical laboratory. Clin Lab Med (2008) 0.75
Fundamentals of pharmacology and applications in pharmacogenetics. Clin Lab Med (2008) 0.75
Undetected hypoglycemia in a patient receiving TPN. Clin Chim Acta (2013) 0.75
The uristatin dipstick is useful in distinguishing upper respiratory from urinary tract infections. Clin Chim Acta (2004) 0.75
An overview of a recent court challenge to the protection of biomarkers as intellectual property. Clin Chim Acta (2011) 0.75
Importance of using gas chromatography for diagnosis of patients poisoned with multiple alcohols. Clin Chim Acta (2007) 0.75
What is next in pharmacogenomics? Translating it to clinical practice. Pharmacogenomics (2003) 0.75
Analysis of ligand binding by bioaffinity mass spectrometry. Clin Chim Acta (2006) 0.75